P/E ratio for Sotera Health (SHC)
P/E ratio as of July 2025 (TTM): 152
According to Sotera Health 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 151.75. At the end of 2024 the company had a P/E ratio of 91.2.
P/E ratio history for Sotera Health from 2020 to 2025
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2024 | 91.2 | -2.58% |
| 2023 | 93.6 | -1032.74% |
| 2022 | -10.0 | -117.9% |
| 2021 | 56.1 | -130.54% |
| 2020 | -184 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Sotera Health
SHC | 152 | 0.00% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.